ACUTA CAPITAL PARTNERS, LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$46,000
+64.3%
73,500
+17.0%
0.02%
+30.8%
Q2 2016$28,000
-97.8%
62,800
-85.5%
0.01%
-97.9%
Q4 2015$1,281,000
-63.4%
434,300
-60.8%
0.61%
-69.8%
Q3 2015$3,504,000
-6.4%
1,108,719
+216.8%
2.03%
-35.6%
Q1 2015$3,742,000
-34.0%
350,000
-42.1%
3.15%
-17.8%
Q4 2014$5,672,000604,0753.83%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,484,649$7,330,0008.59%
Avoro Capital Advisors LLC 5,144,916$15,178,0005.23%
Broadfin Capital, LLC 6,090,829$17,968,0001.10%
Aisling Capital LLC 2,010,000$5,930,0001.02%
Healthcare Value Capital, LLC 150,000$443,0000.73%
ACUTA CAPITAL PARTNERS, LLC 434,300$1,281,0000.61%
WALL STREET ASSOCIATES 696,300$2,054,0000.58%
SEARLE & CO. 172,500$500,0000.48%
Elk Creek Partners, LLC 2,253,667$6,648,0000.47%
KOPP INVESTMENT ADVISORS LLC 315,293$931,0000.46%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders